National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting, 48967 [05-16579]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 161 / Monday, August 22, 2005 / Notices
Dated: August 12, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16578 Filed 8–19–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Arthritis and Musculoskeletal
and Skin Diseases Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), title 5 U.S.C., as
amended. The grant applications and/or
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications
and/or contract proposals, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: September 13, 2005.
Open: 8:30 a.m. to 12 p.m.
Agenda: The meeting will be open to the
public to discuss administrative details
relating to Council business and special
reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Cheryl Kitt, PhD, Director,
Extramural Program, National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, 1 Democracy Blvd., Suite 800,
Bethesda, MD 20892. (301) 594–2463.
kittc@niams.nih.gov.
VerDate jul<14>2003
16:09 Aug 19, 2005
Jkt 205001
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance into the building by nongovernment employees. Persons without
a government I.D. will need to show a
photo I.D. and sign-in at the security
desk upon entering the building.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: August 12, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16579 Filed 8–19–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Review of
Minority Biomedical Research Support
Thematic Project Grants (S11).
Date: September 9, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
conference Call.)
Contact Person: Yan Z. Wang, PhD, MD,
Scientific Review Administrator, National
Institute of Arthritis and Musculoskeletal and
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
48967
Skin Diseases, 6701 Democracy Blvd., Suite
820, Bethesda, MD 20892. (301) 594–4957.
wangy1@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: August 12, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16580 Filed 8–19–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel, Open
Architecture Research Interface for CI.
Date: September 15, 2005.
Time: 2 p.m. to 4 p.m.
Agenda:To review and evaluate contact
proposals.
Place: National Institute of Health, 6120
Executive Blvd., Rockville, MD 20892
(Telephone conference call).
Contact Person: Da-yu Wu, PhD, Scientific
Review Administrator, Scentific Review
Branch, Division of Extramural Activities,
Scientific Review Branch, Division of
Extramural Activities, NIDCD, NIH, 6120
Executive Blvd., Suite 400C, Bethesda, MD
20892, 301–496–8683, wudy@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel, Review of
P50 grant application.
Date: October 5, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\22AUN1.SGM
22AUN1
]]>Agencies
[Federal Register Volume 70, Number 161 (Monday, August 22, 2005)]
[Notices]
[Page 48967]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16579]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Arthritis and Musculoskeletal and Skin Diseases Advisory
Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: September 13, 2005.
Open: 8:30 a.m. to 12 p.m.
Agenda: The meeting will be open to the public to discuss
administrative details relating to Council business and special
reports.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Cheryl Kitt, PhD, Director, Extramural Program,
National Institute of Arthritis and Musculoskeletal and Skin
Diseases, 1 Democracy Blvd., Suite 800, Bethesda, MD 20892. (301)
594-2463. kittc@niams.nih.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government employees.
Persons without a government I.D. will need to show a photo I.D. and
sign-in at the security desk upon entering the building.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: August 12, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-16579 Filed 8-19-05; 8:45 am]
BILLING CODE 4140-01-M
